SIMPEX Guaifenesin
NDC 76457-004, GUAIFENESIN, tablet, from Simpex Pharma Pvt. Ltd.
- Product NDC
- 76457-004
- Status
- Listed
- Labeler
- Simpex Pharma Pvt. Ltd
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76457-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN400 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76457-004-00 | 76457000400 | 100 TABLET in 1 CARTON (76457-004-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 76457-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76457-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76457-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.